Literature DB >> 24817983

Therapy-related B lymphoblastic leukemia with t(4;11)(q21;q23)/AF4-MLL in a patient with mantle cell lymphoma after recent aggressive chemotherapy: a unique case report.

Stephanie L Holdener1, Lacey Harrington1, Johnny Nguyen1, Pedro Horna2, Elizabeth Sagatys2, Bijal Shah3, Ling Zhang2.   

Abstract

Mantle cell lymphoma (MCL) is a mature B-cell lymphoma associated with the hallmark translocation t(11;14)(q13;32), which involves the cyclin D1 (CCND1) and immunoglobin heavy chain (IgH) genes. It may transform to a more aggressive blastoid or pleomorphic variant, with or without acquisition of chromosomal abnormalities. MCL could also present with a leukemic phase with marked lymphocytosis. A literature search did not reveal any prior reports of MCL transforming to or followed by a B-cell lymphoblastic leukemia (B-ALL).

Entities:  

Keywords:  Mantle; lymphoma; therapy; transformation; variant

Mesh：

Substances：

Year:  2014        PMID： 24817983      PMCID： PMC4014267     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  12 in total

1.  Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome.

Authors:  Fanny Rubio-Moscardo; Joan Climent; Reiner Siebert; Miguel A Piris; Jose I Martín-Subero; Inga Nieländer; Javier Garcia-Conde; Martin J S Dyer; Maria Jose Terol; Daniel Pinkel; Jose A Martinez-Climent
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

2.  Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.

Authors:  P J Kurtin; G W Dewald; D J Shields; C A Hanson
Journal:  Am J Clin Pathol       Date:  1996-11       Impact factor: 2.493

3.  Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.

Authors:  M Bernard; R Gressin; F Lefrère; B Drénou; B Branger; S Caulet-Maugendre; P Tass; N Brousse; F Valensi; N Milpied; L Voilat; A Sadoun; C Ghandour; M Hunault; R Leloup; L Mannone; O Hermine; T Lamy
Journal:  Leukemia       Date:  2001-11       Impact factor: 11.528

4.  Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?

Authors:  Guilin Tang; Zhuang Zuo; Deborah A Thomas; Pei Lin; Dingsheng Liu; Ying Hu; Hagop M Kantarjian; Carlos Bueso-Ramos; L Jeffrey Medeiros; Sa A Wang
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

Review 5.  Molecular pathogenesis of mantle cell lymphoma.

Authors:  Pedro Jares; Dolors Colomer; Elias Campo
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 6.  Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.

Authors:  Julie M Vose
Journal:  Am J Hematol       Date:  2012-06       Impact factor: 10.047

7.  Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.

Authors:  N Mauritzson; M Albin; L Rylander; R Billström; T Ahlgren; Z Mikoczy; J Björk; U Strömberg; P G Nilsson; F Mitelman; L Hagmar; B Johansson
Journal:  Leukemia       Date:  2002-12       Impact factor: 11.528

8.  Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders.

Authors:  K F Wong; J K Chan; J C So; P H Yu
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

Review 9.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

10.  High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.

Authors:  S Ishizawa; M L Slovak; L Popplewell; V Bedell; J E Wrede; N H Carter; D S Snyder; D A Arber
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528
View more
  1 in total

Review 1.  Transformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality?

Authors:  Stefano Comazzi; Luca Aresu; Laura Marconato
Journal:  Front Vet Sci       Date:  2015-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.